Cost-Effectiveness Analysis of Laboratory Monitoring in Newly Diagnosed Telogen Effluvium Patients
June 2024
in “
Archives of dermatological research
”
Studysummary Targeted testing for telogen effluvium patients can save healthcare costs.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on link.springer.com →